- Home
- IDYA vs INDV Comparison
IDYA vs INDV Comparison
Compare IDYA & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- INDV
- Stock Information
- Founded
- IDYA 2015
- INDV 1994
- Country
- IDYA United States
- INDV United States
- Employees
- IDYA N/A
- INDV N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- IDYA Health Care
- INDV Health Care
- Exchange
- IDYA Nasdaq
- INDV Nasdaq
- Market Cap
- IDYA 1.9B
- INDV 1.9B
- IPO Year
- IDYA 2019
- INDV N/A
- Fundamental
- Price
- IDYA $24.27
- INDV $17.07
- Analyst Decision
- IDYA Strong Buy
- INDV Strong Buy
- Analyst Count
- IDYA 13
- INDV 3
- Target Price
- IDYA $50.82
- INDV $18.33
- AVG Volume (30 Days)
- IDYA 1.0M
- INDV 2.8M
- Earning Date
- IDYA 08-05-2025
- INDV 07-31-2025
- Dividend Yield
- IDYA N/A
- INDV N/A
- EPS Growth
- IDYA N/A
- INDV N/A
- EPS
- IDYA N/A
- INDV N/A
- Revenue
- IDYA $7,000,000.00
- INDV $1,170,000,000.00
- Revenue This Year
- IDYA $115.83
- INDV N/A
- Revenue Next Year
- IDYA $252.50
- INDV $3.00
- P/E Ratio
- IDYA N/A
- INDV N/A
- Revenue Growth
- IDYA N/A
- INDV 4.09
- 52 Week Low
- IDYA $13.45
- INDV $7.33
- 52 Week High
- IDYA $44.42
- INDV $17.11
- Technical
- Relative Strength Index (RSI)
- IDYA 63.79
- INDV 73.02
- Support Level
- IDYA $21.33
- INDV $15.55
- Resistance Level
- IDYA $25.54
- INDV $16.34
- Average True Range (ATR)
- IDYA 1.00
- INDV 0.49
- MACD
- IDYA 0.20
- INDV 0.07
- Stochastic Oscillator
- IDYA 70.60
- INDV 96.40
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.